# Teva Pharmaceuticals USA clinical trials: 176 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 176 trials with Teva Pharmaceuticals USA as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Teva Pharmaceuticals USA: 176 rows for $8.80, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/teva-pharmaceuticals-usa

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 176
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 176, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| December 19, 2024 | NCT06742957 | Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis | Teva Pharmaceuticals USA | Phase 3 | Completed | Plaque Type Psorisis | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06742957) |
| November 16, 2022 | NCT05617820 | Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With... | Teva Pharmaceuticals USA | Phase 3 | Completed | Dyspareunia | 1,050 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05617820) |
| September 22, 2022 | NCT05550337 | Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris | Teva Pharmaceuticals USA | Phase 3 | Completed | Acne Vulgaris | 807 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05550337) |
| July 26, 2021 | NCT04976192 | Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria | Teva Pharmaceuticals USA | Phase 3 | Completed | Chronic Urticaria | 608 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04976192) |
| January 28, 2021 | NCT04729621 | A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis | Teva Pharmaceuticals USA | Phase 3 | Completed | Osteoporosis, Postmenopausal | 332 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04729621) |
| September 12, 2019 | NCT04088266 | An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change... | Teva Pharmaceuticals USA | Phase 4 | Withdrawn | Evaluation of QTc Interval | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04088266) |
| November 23, 2015 | NCT02611804 | A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3%... | Teva Pharmaceuticals USA | Phase 3 | Completed | Actinic Keratosis | 492 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02611804) |
| September 25, 2014 | NCT02249663 | Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™ | Teva Pharmaceuticals USA | Phase 3 | Unknown | Seasonal Allergic Rhinitis | 1,535 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02249663) |
| September 23, 2014 | NCT02246920 | Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients | Teva Pharmaceuticals USA | Phase 3 | Terminated | Seasonal Allergic Rhinitis | 1,474 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02246920) |
| September 17, 2012 | NCT01686152 | Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis | Teva Pharmaceuticals USA | Phase 3 | Completed | Actinic Keratosis | 589 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01686152) |
| February 1, 2012 | NCT01523236 | Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation | Teva Pharmaceuticals USA | Phase 1/2 | Completed | Seasonal Allergic Rhinitis | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01523236) |
| September 23, 2011 | NCT01439243 | Donepezil 10 mg Tablets Under Fed Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01439243) |
| September 23, 2011 | NCT01439230 | Donepezil 10 mg Tablets Under Fasting Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01439230) |
| April 29, 2011 | NCT01344369 | Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01344369) |
| April 22, 2011 | NCT01340625 | Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Bioequivalence | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01340625) |
| January 25, 2011 | NCT01282814 | Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01282814) |
| January 25, 2011 | NCT01282801 | Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01282801) |
| December 15, 2010 | NCT01260948 | 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01260948) |
| December 15, 2010 | NCT01260922 | 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions. | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01260922) |
| December 15, 2010 | NCT01260896 | Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01260896) |
| November 24, 2010 | NCT01247285 | 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01247285) |
| November 24, 2010 | NCT01247272 | 90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01247272) |
| August 17, 2010 | NCT01183390 | Anastrozole 1 mg Tablets Under Fed Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01183390) |
| August 17, 2010 | NCT01182636 | Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris | Teva Pharmaceuticals USA | Phase 1 | Completed | Acne Vulgaris | 601 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01182636) |
| August 16, 2010 | NCT01182207 | Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions | Teva Pharmaceuticals USA | Phase 1 | Completed | Healthy | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01182207) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 164 |
| Phase 1/2 | 2 |
| Phase 3 | 9 |
| Phase 4 | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 172 |
| Terminated | 2 |
| Withdrawn | 1 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Rhinitis, Allergic, Seasonal | 3 |
| Acne Vulgaris | 2 |
| Keratosis, Actinic | 2 |
| Rhinitis, Allergic | 2 |
| Vaginosis, Bacterial | 1 |
| Vaginal Diseases | 1 |
| Skin Diseases | 1 |
| Skin Diseases, Papulosquamous | 1 |
| Osteoporosis, Postmenopausal | 1 |
| Depressive Disorder | 1 |
| Chronic Urticaria | 1 |
| Dyspareunia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Ethiopian restaurants in the United States](https://specstream.ai/data/businesses/ethiopian-restaurants/united-states)
- [Pediatric gastroenterology practices in the United States](https://specstream.ai/data/businesses/pediatric-gastroenterology-practices/united-states)
- [Appliance repair companies in the United States](https://specstream.ai/data/businesses/appliance-repair-companies/united-states)
- [Financial services firms in the United States](https://specstream.ai/data/businesses/financial-services-firms/united-states)
- [Playground equipment suppliers in the United States](https://specstream.ai/data/businesses/playground-equipment-suppliers/united-states)
